Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Lantern Pharma issues unregistered warrants in private placement for up to 3,669,725 shares

Lantern Pharma issues unregistered warrants in private placement for up to 3,669,725 shares

BitgetBitget2026/09/30 20:01
  • Lantern Pharma closed a concurrent private placement of unregistered warrants to buy up to 3,669,725 common shares.
  • Warrants carry a $1.09 exercise price; exercise starts after stockholder approval of the underlying share issuance.
  • Potential additional gross proceeds total about $4 million if the warrants are fully exercised for cash.
  • Warrants expire five years after stockholder approval; no assurance any warrants will be exercised.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lantern Pharma Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260930166248) on September 30, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!